AstraZeneca COVID-19 Vaccine Information

Disclaimer: The information on this page is intended for Healthcare Professionals only.

Special Approval of medicinal products during public health emergency or pandemic situation for COVID-19 vaccine by AstraZeneca has been granted by the Brunei Darussalam Medicines Control Authority. As with any new medicine in Brunei Darussalam, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Medical Information Inquiries

Reporting of Suspected Adverse Reactions

You can report any suspected adverse reactions via the national reporting system through the Adverse Event Following Immunisation (AEFI) Reporting Form available from the National Adverse Drug Reaction Monitoring Centre (NADRMC) and the nearest government pharmacy facility (hospital/health centre) and include batch/Lot number if available. The completed AEFI Reporting Form should be returned to the nearest government pharmacy facility (hospital/health centre) or e-mail at